Lisinopril

Qbrelis, Zestril

ACE Inhibitor

NADAC/unit $0.0145

No Shortage Tier 1: 448.6% 11 Manufacturers 72 ANDAs

Lisinopril lowers blood pressure by blocking angiotensin-converting enzyme, commonly prescribed for hypertension and heart failure.

vs. brand Qbrelis: Generic saves up to 100% per unit

Covered Lives

Market Intelligence

2024-11-27 Class II Recall: Evaric Pharmaceuticals Inc.

2023-11-29 Class III Recall: NCS Healthcare of Kentucky Inc

Generic Manufacturers

ANNORA PHARMA PRIVATE LTDAUROBINDO PHARMA LTDAZURITY PHARMACEUTICALS INCCHARTWELL RX SCIENCES LLCCOREPHARMA LLCINVAGEN PHARMACEUTICALS INCLUPIN LTDPRINSTON PHARMACEUTICAL INCSCIEGEN PHARMACEUTICALS INCSUN PHARMACEUTICAL INDUSTRIES LTDTWI PHARMACEUTICALS INCWATSON LABORATORIES INCWOCKHARDT BIO AG

Explore in the Ecosystem

rxsaver.aiCompare prices for Lisinopril drfinder.aiFind doctors who prescribe Lisinopril rxnews.aiLatest news about Lisinopril

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.